|
|
|
|
| LEADER |
01055cam a2200325 a 4500 |
| 001 |
INLIS000000000219313 |
| 005 |
20100423100416.16 |
| 006 |
a####g#####i00000# |
| 007 |
ta |
| 008 |
100423s2002####wau####g#####i00000#eng## |
| 020 |
# |
# |
|a 0-8213-5212-1
|
| 022 |
# |
# |
|a 0259-210X
|
| 035 |
# |
# |
|a 0010-41866460
|
| 040 |
# |
# |
|a JKPNPNA
|b eng
|
| 041 |
0 |
# |
|a eng
|
| 082 |
0 |
4 |
|a 615.4
|2 [20]
|
| 090 |
# |
# |
|a U.N. : - 5474 - 2002 no. 437
|
| 100 |
3 |
# |
|a Govindaraj, Ramesh
|
| 245 |
1 |
4 |
|a The Indian pharmaceutical sector :
|b Issues and options for health sector reform/
|c Ramesh Govindaraj, Gnanaraj Chellaraj
|
| 260 |
# |
# |
|a Washington, DC:
|b World Bank,
|c 2002
|
| 300 |
# |
# |
|a xiii, 57 hlm. :
|b tabel ;
|c 28 cm.
|
| 440 |
# |
0 |
|a World Bank discussion paper ;
|v 437
|
| 504 |
# |
# |
|a Bibliografi hlm. 48-59
|
| 650 |
# |
4 |
|a Farmasi
|
| 700 |
3 |
# |
|a Chellaraj, Gnanaraj
|
| 850 |
# |
# |
|a JKPNPNA
|
| 900 |
# |
# |
|a 00765nbm**2200012*a*4500
|
| 902 |
# |
# |
|a 760000576:23-APR-10*760000576:23-APR-10*760000576:23-APR-10*760000576:23-APR-10*
|
| 990 |
# |
# |
|a 192/TIR/MS/2002
|
| 999 |
# |
# |
|a U.N. : -5474 - 2002 No. 437
|
